Bananas Cut Flavanol Absorption by 84% When Blended With Berries
UC Davis research shows blending bananas with berries destroys most flavanols — the compounds tied to heart and brain health.
Summary
New research from UC Davis reveals that adding bananas to berry smoothies can reduce flavanol absorption by up to 84%. The culprit is polyphenol oxidase (PPO), an enzyme abundant in bananas that triggers the browning reaction in cut fruit. When blended with flavanol-rich berries, PPO rapidly degrades these beneficial plant compounds before your body can absorb them. The study tested blood and urine samples after participants consumed banana smoothies, berry smoothies, and flavanol capsules. Berry-only smoothies preserved flavanol levels comparable to the capsule control, while banana smoothies drastically reduced them. Interestingly, even keeping the banana and flavanols separate until consumption still reduced absorption, suggesting PPO may remain active in the stomach. Bananas remain nutritious, but this finding has clear implications for anyone optimizing their smoothie for maximum polyphenol benefit.
Detailed Summary
For health-conscious adults who rely on smoothies to boost polyphenol intake, this study delivers an important and counterintuitive warning: the banana you add for creaminess and potassium may be quietly neutralizing most of the flavanols from your berries, grapes, or cocoa.
Researchers at the University of California, Davis published findings in Food & Function showing that bananas — which are high in the enzyme polyphenol oxidase (PPO) — can reduce flavanol bioavailability by 84% compared to a flavanol capsule control. The same enzyme responsible for browning sliced fruit rapidly degrades flavanols when blended with high-flavanol ingredients like blueberries and blackberries.
The study involved human participants who consumed three preparations: a banana-based smoothie, a mixed berry smoothie, and a flavanol capsule. Blood and urine analyses confirmed that the banana smoothie group had dramatically lower flavanol levels. The berry-only smoothie, made from low-PPO fruits, preserved flavanol levels nearly equivalent to the capsule. A second arm of the study kept bananas and flavanols physically separated until ingestion — yet absorption was still impaired, pointing to potential PPO activity continuing inside the stomach.
This research highlights a broader principle often overlooked in nutrition: bioavailability is not just about what you eat, but how ingredients interact during and after preparation. Even healthy food combinations can undermine specific nutritional goals depending on enzymatic activity.
Practically, this does not mean bananas should be avoided. They remain excellent sources of potassium, fiber, and B6. However, if your smoothie goal is maximizing flavanol intake for cardiovascular and cognitive benefits, pairing bananas with high-flavanol fruits is counterproductive. Swapping bananas for low-PPO alternatives like frozen mango or yogurt could preserve the polyphenol content you're targeting. This study adds meaningful nuance to personalized nutrition and food preparation strategies.
Key Findings
- Banana-berry smoothies reduce flavanol bioavailability by 84% compared to a flavanol capsule control
- The enzyme polyphenol oxidase (PPO), abundant in bananas, degrades flavanols during and possibly after blending
- Mixed berry smoothies without bananas preserved flavanol absorption equivalent to taking a flavanol supplement
- Even separating banana from flavanols until ingestion still reduced absorption, suggesting stomach-level PPO activity
- Swapping bananas for low-PPO fruits in smoothies can preserve heart- and brain-protective flavanol benefits
Methodology
This is a research summary based on a human intervention study published in Food & Function, a peer-reviewed Royal Society of Chemistry journal. The study used biomarker analysis of blood and urine samples from participants consuming controlled smoothie preparations. The lead author is affiliated with both UC Davis and Mars Edge, a Mars, Inc. research unit, which is a noted conflict of interest given Mars's commercial interest in cocoa flavanols.
Study Limitations
The article does not specify sample size or full study design details, limiting assessment of statistical power. The Mars, Inc. affiliation of the lead author introduces potential commercial bias favoring cocoa flavanol research. Long-term health outcome data linking this acute bioavailability reduction to actual disease risk were not reported.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.